United States: A shocking expert revealed that the second-most prescribed thyroid drug consumed by twenty-three million US adults leads to dangerous bone loss bone condition.
More about the news
The medicine is called as Levothyroxine, marketed under the brand name Synthroid, is the second-most commonly prescribed drug, and is used by older adults in the US. The expert report suggests that this comprised seven percent of the US population.
As the drug functions, it takes care of Hypothyroidism, or in other terms, underactive thyroid, by taking place or giving more of a thyroid hormone, which is normally produced by our body.
What more are the experts stating?
The study’s authors, who are from Johns Hopkins Medicine, associated levothyroxine usage with a much greater loss of bone mass and bone density over six years and in older adults with normal thyroid function.

The preliminary study compared the bone health of eighty-one levothyroxine users and 364 nonusers, who were mainly in their early 70s.
As Dr. Shadpour Demehri, co-senior study author and professor of radiology at Johns Hopkins, stated, “Our study suggests that even when following current guidelines, levothyroxine use appears to be associated with greater bone loss in older adults,” the News York Post reported.
The experts, who were also the producers of Synthroid, took into account that consuming too much levothyroxine could lead to higher bone loss, especially in women who are postmenopausal.
What is osteoporosis?
The loss of bone mineral density and bone mass is termed osteoporosis, a form of disease that impacts around ten million US adults who are 50 and older.
Furthermore, as experts describe, bone becomes weak and more likely to break down. With osteoporosis, it becomes very difficult to perform general movement activities and recover from broken bones.
As the New York Post reports, severe fractures could also become a life-threatening situation.
Additionally, Hypothyroidism can also lead to more dangerous and possibly deadly problems if not treated well and on time.
According to r. Elena Ghotbi, the study’s lead author and a postdoctoral research fellow at Johns Hopkins, “Data indicates that a significant proportion of thyroid hormone prescriptions may be given to older adults without hypothyroidism, raising concerns about subsequent relative excess of thyroid hormone even when treatment is targeted to reference range goals.”